Skip to main content

Table 1 Baseline patient characteristics

From: Predictors of radiographic erosion and joint space narrowing progression in patients with early rheumatoid arthritis: a cohort study

 

With radiographic data available from baseline and 5 years (n = 162)

With radiographic data available from baseline and 5 years and DXA at baseline (n = 97)

Demographics and history

 Female sex, n (%)

114 (70)

72 (74)

 Age (years)

62 (52–70)

63 (52–71)

 Symptom duration (months)

7 (5–10)

8 (6–10)

 Time to first DMARD (months)a

5 (3–7)

5 (4–7)

 RF positive, n (%)

105 (65)

56 (58)

 Anti-CCP positive, n (%)

83 (59)

55 (59)

Cigarette smoking status

 Current smokers, n (%)

49 (32)

32 (33)

 Previous smokers, n (%)

51 (33)

33 (34)

 Never smokers, n (%)

55 (36)

32 (33)

Anthropometrics

 BMI (kg/m2)

25 (23–28)

25 (23–27)

 Obese, n (%)b

19 (12)

6 (6)

 Overweight, n (%)b

69 (45)

46 (48)

 Normal BMI, n (%)b

66 (43)

43 (45)

Body composition

 Truncal to peripheral fat ratio

1.08 (0.89–1.27)

1.08 (0.89–1.27)

 Total body fat percentage

35 (27–40)

35 (27–40)

 Fat mass index

8.64 (6.07–10.52)

8.64 (6.07–10.52)

 Fat free mass index

15.60 (14.90–16.97)

15.60 (14.90–16.97)

 Fat mass lean mass index

0.56 (0.39–0.72)

0.56 (0.39–0.72)

  1. Median (IQR) given unless otherwise stated
  2. Missing numbers (radiology only group/radiology + DXA group): Symptom duration = 1/1, time to DMARD = 15/9, cigarette smoking status = 7/-, BMI = 5/1
  3. DMARD disease-modifying anti-rheumatic drug, RF rheumatoid factor, Anti-CCP anti-citrullinated peptide antibodies, BMI body mass index, IQR interquartile range
  4. aDuration from RA symptom onset to start of first DMARD
  5. bDefinitions based on BMI: obese ≥ 30 kg/m2, overweight 25–29.99 kg/m2, normal 18.5–24.99 kg/m2. Three patients with BMI < 18.5 kg/m2 were excluded from analyses of BMI categories